The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Inhibition of Fatty Acid Synthase Attenuates CD44-Associated Signaling and Reduces Metastasis in Colorectal Cancer
Open accessPublished version of a preprint
Abstract
Fatty acid synthase (FASN) and ATP-citrate lyase, key enzymes of de novo lipogenesis, are significantly upregulated and activated in many cancers and portend poor prognosis. Even though the role of lipogenesis in providing proliferative and survival advantages to cancer cells has been described, the impact of aberrant activation of lipogenic enzymes on cancer progression remains unknown. In this study, we found that elevated expression of FASN is associated with advanced stages of colorectal cancer (CRC) and liver metastasis, suggesting that it may play a role in progression of CRC to metastatic disease. Targeted inhibition of lipogenic enzymes abolished expression of CD44, a transmembrane protein associated with metastases in several cancers including CRC. In addition, inhibition of lipogenic enzymes and reduced expression of CD44 attenuated the activation of MET, Akt, FAK, and paxillin, which are known to regulate adhesion, migration, and invasion. These changes were consistent with an observed decrease in migration and adhesion of CRC cells in functional assays and with reorganization of actin cytoskeleton upon FASN inhibition. Despite the modest effect of FASN inhibition on tumor growth in xenografts, attenuation of lipogenesis completely abolished establishment of hepatic metastasis and formation of secondary metastasis. Together, our findings suggest that targeting de novo lipogenesis may be a potential treatment strategy for advanced CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We have previously reported that overexpression of FASN promotes CRC growth and metastasis via multiple mechanisms including upregulation of Cyclin D1 and VEGF secretion [10,29,47,49].”
From Inhibition of fatty acid synthase enhances therapeutic efficacy and delays acquired resistance to BRAF-targeted therapy in colorectal cancer (2026) · cites this paper as [29]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“We and others have previously reported that FASN is highly expressed in CRC [29,30].”
From Inhibition of fatty acid synthase enhances therapeutic efficacy and delays acquired resistance to BRAF-targeted therapy in colorectal cancer (2026) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,077
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann‐Apitius, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,652
MET signalling: principles and functions in development, organ regeneration and cancer
Trusolino, L., Bertotti, A., & Comoglio, P. M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3012 · Cited by 1,272
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Zöller, M. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3023 · Cited by 1,152
Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology
Kuhajda, F. P. (2000) · Nutrition · doi:10.1016/s0899-9007(99)00266-x · Cited by 801
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy
Mashima, T., Seimiya, H., & TSURUO, T. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605007 · Cited by 569
Gulhati, P., Bowen, K. A., Liu, J., Stevens, P. D., Rychahou, P. G., Chen, M., Lee, E. Y., Weiss, H. L., O’Connor, K. L., Gao, T., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4058 · Cited by 544
Self-citationCD44 is required for two consecutive steps in HGF/c-Met signalingPreprint
Orian‐Rousseau, V., Chen, L., Sleeman, J. P., Herrlich, P. A., & Ponta, H. (2002) · Genes & Development · doi:10.1101/gad.242602 · Cited by 518
Cited by
Sorted by citations
Items 101–200 of 209
Peng, H., Wang, Q., Qi, X., Wang, X., & Zhao, X. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4841-2 · Cited by 27
Novel strategies of Raman imaging for exploring cancer lipid reprogramming
Abramczyk, H., Imiela, A., & Śliwińska, A. (2018) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2018.10.082 · Cited by 27
Dharmarajan, S., Newberry, E. P., Montenegro, G. A., Nalbantoglu, I., Davis, V. R., Clanahan, M. J., Blanc, V., Xie, Y., Luo, J., Fleshman, J. W., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0120 · Cited by 26
Fructose and prostate cancer: toward an integrated view of cancer cell metabolism
Carreño, D. V., Corro, N. B., Torres-Estay, V. A., Véliz, L. P., Rodrigo Jaimovich, F., Cisternas, P., Francisco, I. F. S., Sotomayor, P. C., Tanasova, M., Inestrosa, N. C., et al. (2018) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-018-0072-7 · Cited by 26
Lü, J., Bang, H., Kim, S. M., Cho, S., Ashktorab, H., Smoot, D. T., Zheng, C., Ryeom, S. W., Yoon, S. S., Yoon, C., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01571-x · Cited by 26
RetractedFASN Targeted by miR-497-5p Regulates Cell Behaviors in Cervical Cancer
Zhang, H., Wang, R., Tang, X., Li, J., Li, J., & Wang, M. (2022) · Nutrition and Cancer · doi:10.1080/01635581.2022.2036351 · Cited by 25
Jog, E., Jainarayanan, A., Ferlita, A. L., Chakraborty, A., Dalwai, A., Yahya, S., Shivashankar, A., Choudhary, B. S., Chandramouli, A., Kazi, M. K., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103458 · Cited by 26
Sroka, R., Lint, J. V., Katz, S., Schneider, M. R., Kleger, A., Paschke, S., Seufferlein, T. T. W., & Eiseler, T. (2016) · Journal of Cell Science · doi:10.1242/jcs.184721 · Cited by 26
Karasová, M., Procházková, J., Tylichová, Z., Fedr, R., Cigánek, M., Machala, M., Dvořák, Z., Vyhlídalová, B., Bartoňková, I., Ehrmann, J., et al. (2022) · Cancers · doi:10.3390/cancers14174245 · Cited by 25
Gao, W., Pang, D., & Yu, S. (2019) · Journal of International Medical Research · doi:10.1177/0300060519834815 · Cited by 23
Jiang, Y., Tang, Y., Wang, S., Wu, J., Zhang, M., Pang, X., Wu, J., Chen, Y., Tang, Y., & Liang, X. (2019) · Cell Proliferation · doi:10.1111/cpr.12705 · Cited by 23
Yu, X., Mi, S., Ye, J., & Lou, G. (2021) · Journal of Cancer · doi:10.7150/jca.64833 · Cited by 24
Drury, J., Geisen, M. E., Tessmann, J. W., Rychahou, P. G., Kelson, C. O., He, D., Wang, C., Evers, B. M., & Zaytseva, Y. Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094883 · Cited by 25
Self-citationMiki, H., Han, K. H., Scott, D. A., Croft, M., & Kang, Y. J. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900983 · Cited by 22
Drury, J., Young, L. E. A., Scott, T. L., Kelson, C. O., He, D., Liu, J., Wu, Y., Wang, C., Weiss, H. L., Fan, T. W. ‐., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126510 · Cited by 22
Self-citationLi, L., Liu, C. C., Chen, X., Xu, S., Manno, S. H. C., & Cheng, S. H. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00746 · Cited by 21
Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis
Hipólito, A., Martins, F., Mendes, C., Lopes‐Coelho, F., & Serpa, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.656851 · Cited by 21
Meng, Q., Sun, H., Wu, S., Familiari, G., Relucenti, M., Aschner, M., Li, X., & Chen, R. (2022) · Advanced Science · doi:10.1002/advs.202202116 · Cited by 20
Okada, N., Ueki, C., Shimazaki, M., Tsujimoto, G., Kohno, S., Muranaka, H., Yoshikawa, K., & Takahashi, C. (2023) · Communications Biology · doi:10.1038/s42003-023-04987-9 · Cited by 21
Yang, Y., Qi, J., Xu, J., & Hao, P. (2014) · Tumor Biology · doi:10.1007/s13277-014-2316-z · Cited by 20
RetractedDai, W., Wang, Z., Wang, G., Wang, Q. A., DeBerardinis, R. J., & Jiang, L. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112971 · Cited by 20
Mei, H., Yu, X. M., Mei, H., Fang, B., Wang, Q., Cao, D., Hu, Y., & Guo, T. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3857 · Cited by 20
Park, G. B., Chung, Y. H., Gong, J. H., Jin, D., & Kim, D. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3679 · Cited by 20
Menéndez, J. A., Vellón, L., Espinoza, I. C., & Lupu, R. (2016) · Oncoscience · doi:10.18632/oncoscience.314 · Cited by 19
Sattar, R. S. A., Sumi, M. P., Nimisha, Apurva, A., Kumar, A., Sharma, A. K., Ahmad, E., Ali, A., Mahajan, B., & Saluja, S. S. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110080 · Cited by 19
Lee, J., McKinney, K. Q., Pavlopoulos, A. J., Park, J.-H., & Hwang, S. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.10.009 · Cited by 19
Antitumor Therapy Targeting the Tumor Microenvironment
Gao, Y., Pan, Z., Li, H., & Wang, F. (2023) · Journal of Oncology · doi:10.1155/2023/6886135 · Cited by 19
Xiang, H., Hao, J., Zhang, W., Lu, W.-J., Dong, P., Liu, Y., & Chen, L. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.16.6851 · Cited by 18
Profiling of Serum Metabolites in Canine Lymphoma Using Gas Chromatography Mass Spectrometry
TAMAI, R., Furuya, M., Hatoya, S., Akiyoshi, H., Yamamoto, R., KOMORI, Y., Yokoi, S., Kenichiro, T. A. N. I., HIRANO, Y., Komori, M., et al. (2014) · Journal of Veterinary Medical Science · doi:10.1292/jvms.14-0043 · Cited by 18
Guo, D., Wang, Y., Wang, J., Song, L., Wang, Z., Mao, B., & Tan, N. (2019) · Molecules · doi:10.3390/molecules24091829 · Cited by 18
Larson, N. B., Berardi, C., Decker, P. A., Wassel, C. L., Kirsch, P. S., Pankow, J. S., Sale, M. M., de Andrade, M., Sicotte, H., Tang, W., et al. (2015) · Annals of Human Genetics · doi:10.1111/ahg.12119 · Cited by 17
Gjorgjieva, M., Oosterveer, M. H., Mithieux, G., & Rajas, F. (2016) · Journal of Inborn Errors of Metabolism and Screening · doi:10.1177/2326409816679429 · Cited by 17
Yarla, N. S., Madka, V., Pathuri, G., & Rao, C. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249609 · Cited by 15
Prognostic Impact of Fatty Acid Synthase Expression in Upper Urinary Tract Urothelial Carcinoma
Hamada, S., Horiguchi, A., Asano, T., Kuroda, K., Asakuma, J., Ito, K., Asano, T., Miyai, K., & Iwaya, K. (2014) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyu020 · Cited by 15
Pi, W.-S., Cao, Z.-Y., Liu, J., Peng, A.-F., Chen, W., Chen, J., Huang, S.-H., & Liu, Z. (2019) · Technology in Cancer Research & Treatment · doi:10.1177/1533033819853262 · Cited by 15
RetractedCellular Senescence, a Novel Area of Investigation for Metastatic Diseases
Faggioli, F., Velarde, M. C., & Wiley, C. D. (2023) · Cells · doi:10.3390/cells12060860 · Cited by 15
Hepatocyte nuclear factor (HNF)-1β and its physiological importance in endometriosis
Akasaka, J., UEKURI, C., Shigetomi, H., KOIKE, M., & Kobayashi, H. (2012) · Biomedical Reports · doi:10.3892/br.2012.19 · Cited by 14
ATF6 activation alters colonic lipid metabolism causing tumour-associated microbial adaptation
Coleman, O. I., Sorbie, A., Riva, A., von Stern, M., Kuhls, S., Selegato, D. M., Siegert, L., Keidel, I., Köhler, N., Wirbel, J., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01350-6 · Cited by 15
Zhao, Y., Song, T., Ren, P., Wu, X., Luo, Q., Xie, J., Lai, H., Li, X., Wen, Y., Liao, X.-X., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157301 · Cited by 13
Tessmann, J. W., Deng, P., Durham, J., Li, C., Banerjee, M., Wang, Q., Goettl, R. A., He, D., Wang, C., Lee, E. Y., et al. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.142332 · Cited by 13
Self-citationSignalling mechanisms regulating phenotypic changes in breast cancer cells
Volinsky, N., McCarthy, C., von Kriegsheim, A., Šaban, N., Okada, M., Kölch, W., & Kholodenko, B. Ν. (2015) · Bioscience Reports · doi:10.1042/bsr20140172 · Cited by 13
Yun, S., Shin, S.-W., & Park, J. (2017) · Oncology Reports · doi:10.3892/or.2017.6044 · Cited by 13
Regulation of fatty acid synthase on tumor and progress in the development of related therapies
Bai, R., & Cui, J. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002880 · Cited by 15
Dastmalchi, N., Safaralizadeh, R., Khojasteh, S. M. B., Shadbad, M. A., Feizi, M. A. H., Azarbarzin, S., Rajabi, A., & Baradaran, B. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07646-0 · Cited by 12
Song, Y., Wang, J., Xu, J., Gao, Y., & Xu, Z. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23293 · Cited by 12
Narayan, R. R., Harris, J. W., Chou, J. F., Gönen, M., Bao, F., Shia, J., Allen, P. J., Balachandran, V. P., Drebin, J. A., Jarnagin, W. R., et al. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07934-3 · Cited by 12
Yu, W., Ling, J., Yu, H., Du, J., & Liu, T. (2020) · General Physiology and Biophysics · doi:10.4149/gpb_2019061 · Cited by 12
Kelson, C. O., Tessmann, J. W., Geisen, M. E., He, D., Wang, C., Gao, T., Evers, B. M., & Zaytseva, Y. Y. (2024) · Cells · doi:10.3390/cells13191663 · Cited by 12
Self-citationReichel, D., Curtis, L. T., Ehlman, E., Evers, B. M., Rychahou, P. G., Frieboes, H. B., & Bae, Y. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2245-9 · Cited by 11
Self-citationMetabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies
Liefwalker, D. F., Gabay, M., Wang, Z., Pathak, K. V., Plaisier, S. B., Shah, V. M., Babra, B., Dewson, G. S., Lai, I. K., Mosley, A. R., et al. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00263-8 · Cited by 12
Mohamed, A. H., & Said, N. M. (2018) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-018-0104-5 · Cited by 11
LncRNA RPARP-AS1 promotes the progression of osteosarcoma cells through regulating lipid metabolism
Cai, F., Liu, L., Yuan, B., Yan, W., Tao, X., Peng, Y., Zhang, Z., Liao, Q., & Yi, Y. (2024) · BMC Cancer · doi:10.1186/s12885-024-11901-x · Cited by 10
FASN promotes anoikis resistance in colorectal liver metastases through the ERK1/2 pathway
Wu, J., Liu, F., Guo, X., & Cui, C. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150494 · Cited by 10
Hsu, W.-J., Hsu, M.-C., Chu, C., Lee, Y., Yang, C.-C., Liu, Z., Lee, C., Lin, Y.-S., & Lin, C. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103845 · Cited by 12
Lipid Metabolism, Metabolic Syndrome, and Cancer
Hu, F., Zhang, Y., & Song, Y. (2013) · InTech eBooks · doi:10.5772/51821 · Cited by 11
Lipid Handling Protein Gene Expression in Colorectal Cancer: CD36 and Targeting miRNAs
Niculae, A. M., Dobre, M., Herlea, V., Vasilescu, F., Ceafalan, L. C., Trandafir, B., Milanesi, E., & Hinescu, M. E. (2022) · Life · doi:10.3390/life12122127 · Cited by 9
Boelcke, W. P., Teixeira, I. F., Aquino, I. G., Mazzaro, A. R., Zelaya, F. J. M. C., de Souza, A. P., Salo, T. A., Coletta, R. D., Graner, E., & Bastos, D. C. (2021) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2021.105343 · Cited by 9
Wu, S., Gong, Y., Chen, J., Zhao, X., Qing, H., Yan, D., Li, S., Li, J., & Wang, Z. (2022) · Biology Direct · doi:10.1186/s13062-022-00332-y · Cited by 9
Zhang, S., Xu, R., Hu, M., Choueiry, F., Jin, N. Y., Li, J., Mo, X. M., & Zhu, J. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.115978 · Cited by 8
Chen, C.-I., Kuo, D., & Chuang, H. (2025) · International Journal of Radiation Biology · doi:10.1080/09553002.2024.2446585 · Cited by 8
Nor, W., Kwong, S. C., Fuzi, A. A. M., Said, N. A. B. M., Jamil, A. H. A., Lee, Y. Y., Lee, S. C., Lim, Y. A. L., & Chung, I. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5487 · Cited by 10
Metabolic Targets in CRC: The Emerging Role of Cytochrome P450 Inhibitors
Alshakarchi, H. I., Azari, H., Jeddoa, Z. M. A., Jafar, N. N. A., Khazaei, Y., Gataa, I. S., Ferns, G. A., & Avan, A. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128341167250520063502 · Cited by 8
Liu, Y., Xiang, Z., Zhang, B., Zou, Y., Chen, G.-L., Yin, L., Shi, Y., Xu, L.-L., Bi, J., & Wang, Q. (2024) · Aging · doi:10.18632/aging.205872 · Cited by 7
RetractedCircZFR/YTHDF3 axis drives lymph node metastasis in cervical cancer via FASN translation
Zhou, M., Gao, Y., Zhang, Y., Lian, H., Gao, B., Zhang, Y., Claret, F. X., Calin, G. A., & Wang, D. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02424-5 · Cited by 7
Weng, J., Mao, J., Li, Y., Zhao, J., & Nong, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1614498 · Cited by 6
Hon, K. W., & Naidu, R. (2025) · Biomolecules · doi:10.3390/biom15101376 · Cited by 9
Fatty acid synthase in chemoresistance: mechanisms and therapeutic opportunities
Huang, L., Zhang, M., & Xiao, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1674752 · Cited by 4
Li, P., Liang, Y., & Ma, X. (2025) · Molecules · doi:10.3390/molecules30142891 · Cited by 4
The role and mechanism of abnormal lipid metabolism in colorectal cancer
Zha, J., Cang, P., Zhong, Y., Liu, R., & Fan, G. (2025) · Science Progress · doi:10.1177/00368504251368237 · Cited by 4
Impaired Metabolic Pathways Related to Colorectal Cancer Progression and Therapeutic Implications
Chunyan, Q. I. U., Zhang, Y., & Chen, L. (2020) · Iranian Journal of Public Health · doi:10.18502/ijph.v49i1.3052 · Cited by 4
Fatty acid synthase: A key driver of ovarian cancer metastasis and a promising therapeutic target
Ahmad, N., Moton, S., Kuttikrishnan, S., Prabhu, K. S., Masoodi, T., Ahmad, S., & Shahab Uddin, M. S. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155465 · Cited by 4
Yin, M., Li, X., Zhang, S., & Xie, S.-A. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11283-8 · Cited by 3
Heuer, T. S. (2016) · Journal of Cell Signaling · doi:10.4172/2576-1471.1000124 · Cited by 3
Shang, Y., Yang, Q., Zhang, R., Xu, W., EL-Aty, A. M. A., Gao, Y., & Wang, T. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02956-9 · Cited by 2
Chen, C.-I., Chan, H., Shen, C., & Chuang, H. (2024) · Journal of Medical and Biological Engineering · doi:10.1007/s40846-024-00920-5 · Cited by 2
Plasticity in Ovarian Cancer: The Molecular Underpinnings and Phenotypic Heterogeneity
Mukherjee, S., Phadte, P., Mehrotra, M., & Ray, P. (2020) · Journal of the Indian Institute of Science · doi:10.1007/s41745-020-00174-5 · Cited by 2
Global research trends and prospects of cellular metabolism in colorectal cancer
Liu, Y.-C., Gong, Z., Li, C., Teng, P., Chen, Y., & Huang, Z.-H. (2024) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v16.i2.527 · Cited by 2
Khan, A., Siddiqui, S. I., Husain, S. A., Mazurek, S., & Iqbal, M. A. (2020) · doi:10.22541/au.160684227.70170021/v1 · Cited by 2
Borús, D. L., Zadra, G., Minsky, D. M., Costa, M. L., Córsico, B., Storch, J., & Scaglia, N. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2025.159661 · Cited by 2
The Heterogeneous Interplay Between Metabolism and Mitochondrial Activity in Colorectal Cancer
Desterke, C., Fu, Y., Mata-Garrido, J., Hamaï, A., & Chang, Y. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15120571 · Cited by 1
Wéry, C., Montero‐Ruiz, L., Bonneil, É., Farran, M., Jehay, R., Garfia, Q. H., Fettweis, G., Blacher, S., Pottier, C., Cobraiville, G., et al. (2026) · MedComm · doi:10.1002/mco2.70809 · Cited by 1
Park, G. B., & Kim, D. (2016) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-016-3551-3 · Cited by 1
RetractedUng, T., Mason, J. L., Robinson, R. G., Spais, C. M., Ator, M. A., & Angeles, T. S. (2015) · Assay and Drug Development Technologies · doi:10.1089/adt.2015.644 · Cited by 1
Okada, N., Ueki, C., Shimazaki, M., Tsujimoto, G., Kohno, S., Muranaka, H., Yoshikawa, K., & Takahashi, C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.26.493660 · Cited by 1
Geisen, M. E., Tessmann, J. W., Kelson, C. O., He, D., Wang, C., Faisal, A. S. M., Beswick, E. J., Baca, Y., Rock, S., Kolesar, J. M., et al. (2026) · Neoplasia · doi:10.1016/j.neo.2026.101283
“We and others have previously reported that FASN is highly expressed in CRC [29,30].”
Self-citationCharacteristic prediction of colorectal cancer using multi-modality and multi-biomarker imaging
Wang, H., & Tian, J. (2018) · Clinical and Medical Investigations · doi:10.15761/cmi.1000170
Brain Metastasis of Colorectal Cancer: Microenvironment and Molecular Mechanism
Chen, Z., Gu, X., & Zang, Y.-W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801419-6.00016-1
Role of NMR Metabolomics and MR Imaging in Colon Cancer
Kumar, P., & Kumar, V. (2021) · Springer eBooks · doi:10.1007/978-3-030-63369-1_4
Drury, J. (2021) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2021.370
Dai, W., Wang, Z., Wang, G., Wang, Q. A., DeBerardinis, R. J., & Jiang, L. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4164244
Wang, T., Chern, E., Hsu, C., Tseng, K.-C., & Chao, H. (2023) · doi:10.1158/0008-5472.c.6511714.v1
Wang, T., Chern, E., Hsu, C., Tseng, K.-C., & Chao, H. (2023) · doi:10.1158/0008-5472.c.6511714
Elaidy, N. F., Abdelbary, A. M., Qasem, E. R., Eliwa, A., & Ibrahim, H. (2023) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2023.305065
ATF6 activation alters colonic lipid metabolism causing tumor-associated microbial adaptationPreprint
Coleman, O. I., Sorbie, A., Riva, A., von Stern, M., Kuhls, S., Selegato, D. M., Köhler, N., Wirbel, J., Kacprowski, T., Dunkel, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.03.565267
Potential Application Value of FASN in the Diagnosis of Colorectal Cancer
Li, N., Hu, M., Qian, Q., Ouyang, J., Yang, Y., & Zhang, Y. (2025) · JGH Open · doi:10.1002/jgh3.70261
Cai, F., Liu, L., Bo, Y., Yan, W., Tao, X., Peng, Y., Zhang, Z., Liao, Q., & Yi, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26675876
Wu, S., Gong, Y., Chen, J., Zhao, X., Qing, H., Dong, Y., Li, S., Li, J., & Wang, Z. (2022) · Figshare · doi:10.6084/m9.figshare.20400909
Wu, S., Gong, Y., Chen, J., Zhao, X., Qing, H., Dong, Y., Li, S., Li, J., & Wang, Z. (2022) · Figshare · doi:10.6084/m9.figshare.20400912
Cai, F., Liu, L., Bo, Y., Yan, W., Tao, X., Peng, Y., Zhang, Z., Liao, Q., & Yi, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25137964
Cai, F., Liu, L., Bo, Y., Yan, W., Tao, X., Peng, Y., Zhang, Z., Liao, Q., & Yi, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25138041
Metadata
- Authors
- Zaytseva, Y. Y., Rychahou, P. G., Gulhati, P., Elliott, V. A., Mustain, W. C., O'Connor, K., Morris, A. J., Sunkara, M., Weiss, H. L., Lee, E. Y., & Evers, B. M.
- Affiliations
- University of Kentucky (US)
- Authors' Affiliations: 1Markey Cancer Center, Departments of 2Surgery and 3Pathology and Laboratory Medicine, 4Division of Cardiovascular Medicine, and 5Gill Heart Institute, University of Kentucky, Lexington, Kentucky
- Corresponding author
- Evers, B. Mark
- ORCID
- Venue
- Cancer Research
- Published
- 2012-03-14
- Volume
- 72
- Issue
- 6
- Pages
- 1504-1517
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC3596828
- OpenAlex
- W1997243908
- Cited by
- 208
- References
- 52
- Citations by year
- 2026: 6 · 2025: 17 · 2024: 19 · 2023: 12 · 2022: 17 · 2021: 19 · 2020: 17 · 2019: 11 · 2018: 18 · 2017: 8 · 2016: 19 · 2015: 13 · 2014: 22 · 2013: 7 · 2012: 3
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UKnowledge (University of Kentucky) (submittedVersion)
- Funders
- National Cancer Institute (P20CA150343, R01CA109136, P20CA1530343, T32CA165990)
- National Institute of General Medical Sciences (GM-50388, R01GM050388)
- National Center for Research Resources (S10RR026884, S10RR024598, P20RR021954)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- fatty acid synthase, ATP citrate lyase, de novo lipogenesis, colorectal cancer, liver metastasis, CD44, C-MET signaling, Akt signaling, focal adhesion kinase, paxillin, cell migration, cell adhesion, actin cytoskeleton
- MeSH terms
- Animals, Humans, Liver Neoplasms, Male, Mice, Nude, Colorectal Neoplasms, Signal Transduction, Down-Regulation, Hyaluronan Receptors, Proto-Oncogene Proteins c-met, Xenograft Model Antitumor Assays, Cell Line, Tumor, Lipogenesis, Oncogene Protein v-akt, Mice, Focal Adhesion Kinase 1, Paxillin, Gene Knockdown Techniques, Fatty Acid Synthases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review